Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Esketamine
Related studies linked through entity extraction aliases.
Intraoperative Small-dose Esketamine Infusion for Pain Control in Burn Patients
- Status
- UNKNOWN
- Phase
- PHASE4
The Study on the Esketamine in the Treatment of Postherpetic Neuralgia
- Status
- UNKNOWN
- Phase
- PHASE4
Esketamine Sedation and Fentanyl Sedation in Pediatric Dental Patients
- Status
- COMPLETED
- Phase
- PHASE4
Imaging Neural Correlates of Ketamine Using PET/MR
- Status
- RECRUITING
- Phase
- PHASE1
A Multicenter Study of the Efficacy and Safety of Esketamine for Analgesia During Cesarean Section
- Status
- COMPLETED
- Phase
- PHASE4
University of Iowa Interventional Psychiatry Service Patient Registry
- Status
- RECRUITING
- Phase
- N/A
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
- Status
- COMPLETED
- Phase
- PHASE3
Esketamine and Perioperative Depressive Symptoms
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)
- Status
- RECRUITING
- Phase
- PHASE4
Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
- Status
- RECRUITING
- Phase
- NA
Intranasal Esketamine and Fentanyl for Pain in Minor Trauma
- Status
- UNKNOWN
- Phase
- PHASE4
A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide
- Status
- COMPLETED
- Phase
- PHASE2
54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
- Status
- COMPLETED
- Phase
- PHASE3
54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1